Influence of Cooling Agents on the Arrhythmogenic and Autonomic Effects of Electronic Cigarettes in an in vivo Model.
C, K., AR, R., SM, R., R, P., S, S., PK, L., A, B., MA, N., & AP, C. (2026). Influence of Cooling Agents on the Arrhythmogenic and Autonomic Effects of Electronic Cigarettes in an in vivo Model.. Circulation. Arrhythmia and electrophysiology. https://doi.org/10.1161/CIRCEP.125.014253
C K, AR R, SM R, R P, S S, PK L, et al. Influence of Cooling Agents on the Arrhythmogenic and Autonomic Effects of Electronic Cigarettes in an in vivo Model.. Circulation. Arrhythmia and electrophysiology. 2026; doi: 10.1161/CIRCEP.125.014253
C K, AR R, SM R, et al. Influence of Cooling Agents on the Arrhythmogenic and Autonomic Effects of Electronic Cigarettes in an in vivo Model.[J]. Circulation. Arrhythmia and electrophysiology. 2026. DOI: 10.1161/CIRCEP.125.014253.
@article{c2026,
author = {Kucera C and Ramalingam AR and Raph SM and Paily R and Srivastava S and Lorkiewicz PK and Bhatnagar A and Nystoriak MA and Carll AP},
title = {Influence of Cooling Agents on the Arrhythmogenic and Autonomic Effects of Electronic Cigarettes in an in vivo Model.},
journal = {Circulation. Arrhythmia and electrophysiology},
year = {2026},
doi = {10.1161/CIRCEP.125.014253},
note = {PMID: 42290371},
}
TY - JOUR AU - Kucera C AU - Ramalingam AR AU - Raph SM AU - Paily R AU - Srivastava S AU - Lorkiewicz PK AU - Bhatnagar A AU - Nystoriak MA AU - Carll AP TI - Influence of Cooling Agents on the Arrhythmogenic and Autonomic Effects of Electronic Cigarettes in an in vivo Model. T2 - Circulation. Arrhythmia and electrophysiology PY - 2026 DO - 10.1161/CIRCEP.125.014253 AN - PMID:42290371 ER -
BACKGROUND: Despite the growing popularity of electronic cigarettes, evidence is mounting that vaping induces autonomic nervous system imbalance, cardiac arrhythmia, and potentially even cardiac arrest. The ingredients menthol, WS-3, and WS-23 are cooling agents that enhance the appeal of electronic cigarettes (e-cigs) but bear unknown risks when inhaled. METHODS: We systematically evaluated how these coolants influence the impacts of e-cigs on cardiac and cellular electrophysiology in mice and human induced pluripotent stem cell-derived cardiomyocytes, respectively. Mice were exposed by inhalation to e-cig aerosols generated from standard e-liquid solvents and 2.5% nicotine benzoate (vehicle), or from vehicle plus menthol, WS-3, or WS-23, at increasing concentrations throughout exposure. Telemetry-derived electrocardiograms were analyzed for changes in heart rate, heart rate variability, morphology, and ventricular premature beat arrhythmias. Human induced pluripotent stem cell-derived cardiomyocytes were evaluated for the effects of serially increasing coolant concentrations on beat rate, electric field potential duration, and rate-corrected field potential duration from a newly validated formula, in the absence and presence of norepinephrine to simulate basal physiology and nicotine-evoked sympathoexcitation. RESULTS: Upon e-cig aerosol inhalation, all coolants acutely enhanced vehicle-induced autonomic imbalance, but only the synthetic coolants, WS-3 and WS-23, potentiated ventricular arrhythmogenesis. Ventricular premature beats during e-cig exposures correlated with sympathetic dominance and transient delays in ventricular repolarization measured by heart rate variability and rate-corrected QT interval, respectively; however, correlations were strongest for WS-23 despite no significant impact of coolants on nicotine intake. Conversely, in human induced pluripotent stem cell-derived cardiomyocytes, coolants did not affect basal physiology but slowed beat rate and shortened rate-corrected field potential duration during norepinephrine stimulation. CONCLUSIONS: Together, these data indicate that coolants dose-dependently enhance the arrhythmogenicity of e-cigs, likely through acute alterations in autonomic modulation and repolarization. Pending confirmation by human studies, these common non-nicotine additives may exacerbate e-cig cardiotoxicity and pose unique cardiovascular risks, particularly in those with arrhythmogenic susceptibility to sympathetic stimulation or slowed ventricular repolarization.